Save your place

Sign in to WhoBought

Please try again later.

Cardiff Oncology, Inc. (CRDF) institutional ownership

Latest close $0.84 Jul 20, 2026
Market cap$176M 52-week range SectorHealthcare
Funds holding · Q1 2026
98
reported CRDF position changes
Top owners · Q1 2026
No disclosed owners are available.
Institutional activity · Q1 2026
Activity unavailable N/A
48 buyers · 50 sellers

Cardiff Oncology, Inc. (CRDF) price and institutional activity

Dates

Q1 2026

$0 bought by 48 investors
UBS Group AGRenaissance Technologies LLC +46 more
$0 sold by 50 investors
Blair William & CoTwo Sigma Investments, LP +48 more
Bought Sold Totals per quarter; hover a bar for the names.

Cardiff Oncology, Inc. (CRDF) institutional activity · 98

Investor Type Est. change Change Δ Own Date
Blair William & Co · Reduced
Change −1.0M Date Q1 2026
Blair William & Co Reduced· Q1 2026 −1.0M Q1 2026
Two Sigma Investments, LP · Reduced
Change −518K Δ Own −71.4% Date Q1 2026
Two Sigma Investments, LP Reduced· Q1 2026 −518K −71.4% Q1 2026
Two Sigma Advisers, LP · Exited
Change −360K Δ Own −100.0% Date Q1 2026
Two Sigma Advisers, LP Exited· Q1 2026 −360K −100.0% Q1 2026
Candriam S.c.a. · Exited
Change −344K Δ Own −100.0% Date Q1 2026
Candriam S.c.a. Exited· Q1 2026 −344K −100.0% Q1 2026
UBS Group AG · Added
Change +313K Date Q1 2026
UBS Group AG Added· Q1 2026 +313K Q1 2026
Goldman Sachs Group Inc · Reduced
Change −249K Date Q1 2026
Goldman Sachs Group Inc Reduced· Q1 2026 −249K Q1 2026
Acorn Capital Advisors, LLC · Reduced
Change −200K Date Q1 2026
Acorn Capital Advisors, LLC Reduced· Q1 2026 −200K Q1 2026
Morgan Stanley · Reduced
Change −180K Date Q1 2026
Morgan Stanley Reduced· Q1 2026 −180K Q1 2026
Millennium Management LLC · Reduced
Change −171K Date Q1 2026
Millennium Management LLC Reduced· Q1 2026 −171K Q1 2026
Renaissance Technologies LLC New· Q1 2026 +101K Q1 2026
Jane Street Group, LLC · Reduced
Change −93K Date Q1 2026
Jane Street Group, LLC Reduced· Q1 2026 −93K Q1 2026
Gsa Capital Partners LLP · Reduced
Change −88K Date Q1 2026
Gsa Capital Partners LLP Reduced· Q1 2026 −88K Q1 2026
Barclays PLC · Reduced
Change −87K Date Q1 2026
Barclays PLC Reduced· Q1 2026 −87K Q1 2026
Geode · Added
Change +77K Date Q1 2026
Geode Added· Q1 2026 +77K Q1 2026
Hb Wealth Management, LLC · Exited
Change −71K Δ Own −100.0% Date Q1 2026
Hb Wealth Management, LLC Exited· Q1 2026 −71K −100.0% Q1 2026
Data through Q1 2026 · filed Jun 3, 2026
15 of 98

Famous investor activity in Cardiff Oncology, Inc. (CRDF)

Cardiff Oncology, Inc. (CRDF) insider trading

Company insiders, action and economics first; trade and filed dates last.
Dates
Insider Title Type Price Qty Value Owned ΔOwn Trade date Filed date
Pace Gary W. · Director Buy +$1000K
Price $1.46 Qty +687K Owned 2.0M ΔOwn +50.7% Trade date Jul 14, 2026 Filed date Jul 16, 2026
Pace Gary W. Director Buy $1.46 +687K +$1000K 2.0M +50.7% Jul 14, 2026 Jul 16, 2026
Pace Gary W. · Director Other Form 4 event (P, derivative) 687K
Owned 687K Trade date Jul 14, 2026 Filed date Jul 16, 2026
Pace Gary W. Director Other Form 4 event (P, derivative) 687K 687K Jul 14, 2026 Jul 16, 2026
Mohindru Mani · Director Buy +$50K
Price $1.46 Qty +34K Owned 59K ΔOwn +139.1% Trade date Jul 14, 2026 Filed date Jul 16, 2026
Mohindru Mani Director Buy $1.46 +34K +$50K 59K +139.1% Jul 14, 2026 Jul 16, 2026
Mohindru Mani · Director Other Form 4 event (P, derivative) 34K
Owned 34K Trade date Jul 14, 2026 Filed date Jul 16, 2026
Mohindru Mani Director Other Form 4 event (P, derivative) 34K 34K Jul 14, 2026 Jul 16, 2026
Mohindru Mani · Director Buy +$30K
Price $1.21 Qty +25K Owned 25K Trade date Jun 18, 2026 Filed date Jun 22, 2026
Mohindru Mani Director Buy $1.21 +25K +$30K 25K Jun 18, 2026 Jun 22, 2026
Pace Gary W. · Director Buy +$37K
Price $1.22 Qty +30K Owned 1.4M ΔOwn +2.3% Trade date Jun 18, 2026 Filed date Jun 22, 2026
Pace Gary W. Director Buy $1.22 +30K +$37K 1.4M +2.3% Jun 18, 2026 Jun 22, 2026
Armitage James O. · Director Grant (A) 41K
Owned 228K Trade date Jun 11, 2026 Filed date Jun 15, 2026
Armitage James O. Director Grant (A) 41K 228K Jun 11, 2026 Jun 15, 2026
White Lale · Director Grant (A) 41K
Owned 199K Trade date Jun 11, 2026 Filed date Jun 15, 2026
White Lale Director Grant (A) 41K 199K Jun 11, 2026 Jun 15, 2026
Tannenbaum Renee P. · Director Grant (A) 41K
Owned 209K Trade date Jun 11, 2026 Filed date Jun 15, 2026
Tannenbaum Renee P. Director Grant (A) 41K 209K Jun 11, 2026 Jun 15, 2026
Markin Rodney S. · Director Grant (A) 41K
Owned 263K Trade date Jun 11, 2026 Filed date Jun 15, 2026
Markin Rodney S. Director Grant (A) 41K 263K Jun 11, 2026 Jun 15, 2026
Pace Gary W. · Director Grant (A) 41K
Owned 228K Trade date Jun 11, 2026 Filed date Jun 15, 2026
Pace Gary W. Director Grant (A) 41K 228K Jun 11, 2026 Jun 15, 2026
Aggarwal Ajay · Officer Grant (A) 400K
Owned 400K Trade date Apr 27, 2026 Filed date Apr 28, 2026
Aggarwal Ajay Officer Grant (A) 400K 400K Apr 27, 2026 Apr 28, 2026
Smeal Tod · Officer Grant (A) 300K
Owned 1.3M Trade date Apr 14, 2026 Filed date Apr 16, 2026
Smeal Tod Officer Grant (A) 300K 1.3M Apr 14, 2026 Apr 16, 2026
Muntner Joshua B. · CFO Grant (A) 487K
Owned 487K Trade date Apr 6, 2026 Filed date Apr 16, 2026
Muntner Joshua B. CFO Grant (A) 487K 487K Apr 6, 2026 Apr 16, 2026
Mohindru Mani · Director Grant (A) 600K
Owned 969K Trade date Mar 31, 2026 Filed date Apr 2, 2026
Mohindru Mani Director Grant (A) 600K 969K Mar 31, 2026 Apr 2, 2026
15 of 18
15 of 18 Sign in to continue to older insider transactions.

Cardiff Oncology, Inc. (CRDF) activist and large shareholders

Dates
Owner/Filer identity Shares reported % of shares outstanding Filing date
Caxton Corp 3.5M
% of shares outstanding 8.1% Filing date Feb 14, 2022
Caxton Corp 3.5M 8.1% Feb 14, 2022
Acorn Bioventures, L.P. 3.0M
% of shares outstanding 6.4% Filing date Jan 26, 2023
Acorn Bioventures, L.P. 3.0M 6.4% Jan 26, 2023
Blackrock, Inc. 2.7M
% of shares outstanding 5.9% Filing date Nov 8, 2024
Blackrock, Inc. 2.7M 5.9% Nov 8, 2024
Pfizer Inc 2.4M
% of shares outstanding 5.8% Filing date Nov 19, 2021
Pfizer Inc 2.4M 5.8% Nov 19, 2021
Acorn Bioventures, L.P. 1.9M
% of shares outstanding 4.2% Filing date Feb 6, 2024
Acorn Bioventures, L.P. 1.9M 4.2% Feb 6, 2024
Caxton Corp 984K
% of shares outstanding 2.2% Filing date Feb 14, 2023
Caxton Corp 984K 2.2% Feb 14, 2023
State Street Corp
% of shares outstanding 1.6% Filing date Feb 9, 2022
State Street Corp 1.6% Feb 9, 2022
BlackRock Inc. 672K
% of shares outstanding 1.6% Filing date Jul 8, 2022
BlackRock Inc. 672K 1.6% Jul 8, 2022
8 of 13

Cardiff Oncology, Inc. (CRDF) ownership FAQ

Who owns CRDF?

98 reporting institutions disclosed CRDF position changes in the Q1 2026 snapshot.

How is institutional activity calculated?

For each manager, WhoBought compares accepted consecutive 13F share counts. Share change is current shares minus prior shares. Estimated dollar change is that signed share change multiplied by the split-adjusted quarter-mean close. The activity table on this page uses Q1 2026.

What are activist and large shareholder filings?

An investor crossing 5% of a share class generally files Schedule 13D for activist intent or Schedule 13G for a passive position. The technical form names appear here rather than in the activity rows.

Where does this data come from?

Ownership and institutional activity come from SEC Form 13F filings. Insider activity comes from SEC Form 4, and large-shareholder activity from SEC Schedules 13D and 13G. FMP supplies price data only. Company logos use the local verified Parqet cache with one shared fallback.

Why are ownership reports delayed?

Form 13F is a quarterly disclosure and is normally filed after the quarter ends. Every ownership and activity value therefore names its represented period; it is not presented as a live position.

How are missing table values shown?

A muted dash marks a missing table value. It means the filing omitted the value, comparable data is unavailable, or no prior position exists for comparison.